11216 Federal Register / Vol. 62, No. 47 / Tuesday, March 11, 1997 / Notices

Place: Ramada Bethesda, 8400 Wisconsin

Avenue, Bethesda, MD 20814 (301) 654–

1000.

Contact Person: Dr. Stanley Oaks,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C06,

Bethesda, MD 20892 (301) 496–7042.

Purpose/Agenda: To evaluate grant

applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health.)

Dated: March 5, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–6005 Filed 3–10–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meetings:

Name of SEP: Expanded Research on

Emerging Diseases (Telephone Conference

Call).

Date: March 19, 1997.

Time: 10:00 a.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Contact Person: Dr. Peter R. Jackson,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

Name of SEP: Mechanisms of

Immunopathology in DHF/DSS (Telephone

Conference Call).

Date: March 20, 1997.

Time: 10:00 a.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Contact Person: Dr. Peter R. Jackson,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the review and funding cycle.

Name of SEP: Expanded Research on

Emerging Diseases (Telephone Conference

Call).

Date: April 3, 1997.

Time: 2:00 p.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Contact Person: Dr. Peter R. Jackson,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health.)

Dated: March 5, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–6007 Filed 3–10–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meetings:

Name of SEP: Expanded Research on

Emerging Diseases (Telephone Conference

Call).

Date: March 27, 1997.

Time: 10:00 a.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Contact Person: Dr. Peter R. Jackson,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892 (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

Name of SEP: Expanded Research on

Emerging Diseases (Telephone Conference

Call).

Date: March 27, 1997.

Time: 1:00 p.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Contact Person: Dr. Peter R. Jackson,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892 (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

Name of SEP: Expanded Research on

Emerging Diseases (Telephone Conference

Call).

Date: March 27, 1997.

Time: 2:30 p.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892, (301) 496–2550.

Contact Person: Dr. Peter R. Jackson,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892 (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health.)

Dated: March 5, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–6008 Filed 3–10–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meetings:

Name of SEP: Expanded Research on

Emerging Diseases (Telephone Conference

Call).

Date: March 24, 1997.

Time: 11:00 a.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892 (301) 496–2550.

Contact Person: Dr. Peter R. Jackson,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892 (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

Name of SEP: Expanded Research on

Emerging Diseases (Telephone Conference

Call).

Date: March 24, 1997.

Time: 1:00 p.m.

Place: Teleconference, 6003 Executive

Boulevard, Solar Bldg., Room 4C10,

Bethesda, MD 20892 (301) 496–2550.